PDCD1 and neoplasm: Importantly, Li et al. demonstrated that the combination of the demethylating agent decitabine and anti-PD-1 antibody can promote the activation and expansion of progenitor exhausted CD8+ T cells, effectively suppressing tumor growth in mice [21].